Catalyst Wire Dossier Catalyst Wire Dossier

Kyntheum

brodalumab · LEO Pharma A/S
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Kyntheum, covering 2025-08-27 to 2025-08-27. Get the full timeline:

Most recent: EMA Authorised: Kyntheum (brodalumab) — LEO Pharma A/S

See pricing